Cardio-vascular risk factors, treatment and disease characteristics in the HIV− and HIV+ groups.
收藏Figshare2015-12-02 更新2026-04-29 收录
下载链接：
https://figshare.com/articles/dataset/_Cardio_vascular_risk_factors_treatment_and_disease_characteristics_in_the_HIV_8722_and_HIV_groups_/687003
下载链接
链接失效反馈官方服务：
资源简介：
1Atrial fibrillation, Myocardial infarction, congestive heart failure, peripheral arteriosclerosis, carotid/coronary arteriosclerosis.2This information was specifically part of the D.A.D. score and was entered as “yes” vs “no” for Abacavir and as the duration in months for Lopinavir/Ritonavir and Indinavir.Note that there was a strong correlation between the Framingham score and the D.A.D. score in the HIV+ group (r = .67; pr = .31; pr = .38; pStandard assays for Cholesterol, Reference Intervals: 0.0–6.0 mmol/L; Auto Chemistry (8382–9164).Standard assays for HDL Cholesterol, Reference Intervals: >1.0 mmol/L; Auto Chemistry (8382–9164).Standard assays for High-sensitivity C Reactive Protein(hs-CRP), Reference Intervals:
创建时间：
2015-12-02
